Aleksandar Rajkovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Aleksandar Rajkovic has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
- Stephanie A. Pangas
Department of Pathology and Immunology, Baylor College of Medicine, Houston, TX, USA
3 shared publications Martin M. Matzuk
Departments of *Pathology
2 shared publicationsA.A. Skillern
1 shared publicationD. Ballow
1 shared publicationD. Yuan
1 shared publicationDaniel Ballow
Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, TX 77030, USA
1 shared publication
Latest Publications
- 30 September 2009
- Published by Elsevier in Fertility and Sterility
- Vol. 92 (3) , S66
Primordial follicle destruction by cyclophosphamide in the murine model: the protective effect of the Nobox heterozygote genotype
- 30 September 2009
- Published by Elsevier in Fertility and Sterility
- Vol. 92 (3) , S66
Primordial follicle destruction by cyclophosphamide in the murine model: the protective effect of the Nobox heterozygote genotype
- Open Access
- 30 June 2009
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 15 (9) , 563-568
Detection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays
Uterine leiomyomas (ULs) are benign monoclonal tumors originating from myometrial tissue in the uterus. Genetic pathways that lead to myometrial transformation into leiomyomas are largely unknown. Approximately 40% of ULs are karyotypically abnormal by G-banding; however, the remaining 60% of leiomyomas do not contain cytogenetically visible genomic rearrangements. Recent technological advances such as array based comparative genomic hybridization (array CGH) and dense single nucleotide polymorphism (SNP) arrays have enabled genome-wide scanning for genomic rearrangements missed by karyotype banding analysis. In the current study, we employed a high resolution SNP microarray on 16 randomly selected ULs and normal myometrium samples to detect submicroscopic (5 Mb, whereas 31% of which (5/16) contained only submicroscopic copy number changes (RHOU, MAP3K11 and WASF3 gene copy numbers were changed in the subset of leiomyomas with submicroscopic aberrations, and these genes have previously been implicated in tumorigenesis. Our findings support the hypothesis that a significant fraction of ULs without visible cytogenetic changes harbor submicroscopic genomic rearrangements which may in turn contribute to transformation of normal myometrial tissue into leiomyomas.
- 30 June 2009
- Published by Oxford University Press (OUP) in Molecular Human Reproduction
- Vol. 15 (9) , 563-568
Open AccessDetection of novel copy number variants in uterine leiomyomas using high-resolution SNP arrays
Uterine leiomyomas (ULs) are benign monoclonal tumors originating from myometrial tissue in the uterus. Genetic pathways that lead to myometrial transformation into leiomyomas are largely unknown. Approximately 40% of ULs are karyotypically abnormal by G-banding; however, the remaining 60% of leiomyomas do not contain cytogenetically visible genomic rearrangements. Recent technological advances such as array based comparative genomic hybridization (array CGH) and dense single nucleotide polymorphism (SNP) arrays have enabled genome-wide scanning for genomic rearrangements missed by karyotype banding analysis. In the current study, we employed a high resolution SNP microarray on 16 randomly selected ULs and normal myometrium samples to detect submicroscopic (5 Mb, whereas 31% of which (5/16) contained only submicroscopic copy number changes (RHOU, MAP3K11 and WASF3 gene copy numbers were changed in the subset of leiomyomas with submicroscopic aberrations, and these genes have previously been implicated in tumorigenesis. Our findings support the hypothesis that a significant fraction of ULs without visible cytogenetic changes harbor submicroscopic genomic rearrangements which may in turn contribute to transformation of normal myometrial tissue into leiomyomas.
- 23 May 2006
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (21) , 8090-8095
Oogenesis requires germ cell-specific transcriptional regulators Sohlh1 and Lhx8
Mammalian oogenesis requires oocyte-specific transcriptional regulators. The full complement of oocyte-specific transcription factors is unknown. Here, we describe the finding that Sohlh1 , a spermatogenesis and oogenesis basic helix–loop–helix transcription factor in females, is preferentially expressed in oocytes and required for oogenesis. Sohlh1 disruption perturbs follicular formation in part by causing down-regulation of two genes that are known to disrupt folliculogenesis: newborn ovary homeobox gene ( Nobox ) and factor in the germ-line alpha ( Figla ). In addition, we show that Lhx8 is downstream of Sohlh1 and critical in fertility. Thus, Sohlh1 and Lhx8 are two germ cell-specific, critical regulators of oogenesis.
- 23 May 2006
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 103 (21) , 8090-8095
Oogenesis requires germ cell-specific transcriptional regulators Sohlh1 and Lhx8
Mammalian oogenesis requires oocyte-specific transcriptional regulators. The full complement of oocyte-specific transcription factors is unknown. Here, we describe the finding that Sohlh1 , a spermatogenesis and oogenesis basic helix–loop–helix transcription factor in females, is preferentially expressed in oocytes and required for oogenesis. Sohlh1 disruption perturbs follicular formation in part by causing down-regulation of two genes that are known to disrupt folliculogenesis: newborn ovary homeobox gene ( Nobox ) and factor in the germ-line alpha ( Figla ). In addition, we show that Lhx8 is downstream of Sohlh1 and critical in fertility. Thus, Sohlh1 and Lhx8 are two germ cell-specific, critical regulators of oogenesis.
- 16 January 2006
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 63 (5) , 579-590
Genetics of early mammalian folliculogenesis
Early ovarian folliculogenesis begins with the breakdown of germ cell clusters and formation of primordial follicles. Primordial follicles are the smallest ovarian follicle units continuously recruited to grow into primary and more advanced ovarian follicles. Genes expressed in the germ cells such as Figla, Nobox, Kit and Ntrk2, as well as genes expressed in the surrounding somatic cells such as Foxl2, Kitl and Ngf, play critical functions during early folliculogenesis. Transgenic mice continue to provide important insights into the genetic pathways that regulate early mammalian folliculogenesis. Genes critical in early folliculogenesis are important determinants of reproductive life span and represent candidate genes for human ovarian failure.
- 16 January 2006
- Published by Springer Nature in Cellular and Molecular Life Sciences
- Vol. 63 (5) , 579-590
Genetics of early mammalian folliculogenesis
Early ovarian folliculogenesis begins with the breakdown of germ cell clusters and formation of primordial follicles. Primordial follicles are the smallest ovarian follicle units continuously recruited to grow into primary and more advanced ovarian follicles. Genes expressed in the germ cells such as Figla, Nobox, Kit and Ntrk2, as well as genes expressed in the surrounding somatic cells such as Foxl2, Kitl and Ngf, play critical functions during early folliculogenesis. Transgenic mice continue to provide important insights into the genetic pathways that regulate early mammalian folliculogenesis. Genes critical in early folliculogenesis are important determinants of reproductive life span and represent candidate genes for human ovarian failure.
- Open Access
- 2 September 2005
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 12 (1) , 65-76
Transcriptional regulation of early oogenesis: in search of masters
Transcription factors in the germline play important roles in ovary formation and folliculogenesis, and control both oocyte development and somatic cell function. Factor in the germline (Figla) and newborn ovary homeobox gene (Nobox) represent a growing number of oocyte-specific transcription factors that regulate genes unique to oocytes. Studies on oocyte-specific transcription factors are important in understanding the genetic pathways essential for oogenesis, pluripotency, and embryonic development. Likely, these genes regulate reproductive life span and represent candidate genes for reproductive disorders, such as premature ovarian failure, and infertility. Therefore, oocyte-specific transcription factors, and oocyte-specific genes regulated by such factors, are attractive tissue-specific pharmacological targets to regulate human fertility.
- 2 September 2005
- Published by Oxford University Press (OUP) in Human Reproduction Update
- Vol. 12 (1) , 65-76
Open AccessTranscriptional regulation of early oogenesis: in search of masters
Transcription factors in the germline play important roles in ovary formation and folliculogenesis, and control both oocyte development and somatic cell function. Factor in the germline (Figla) and newborn ovary homeobox gene (Nobox) represent a growing number of oocyte-specific transcription factors that regulate genes unique to oocytes. Studies on oocyte-specific transcription factors are important in understanding the genetic pathways essential for oogenesis, pluripotency, and embryonic development. Likely, these genes regulate reproductive life span and represent candidate genes for reproductive disorders, such as premature ovarian failure, and infertility. Therefore, oocyte-specific transcription factors, and oocyte-specific genes regulated by such factors, are attractive tissue-specific pharmacological targets to regulate human fertility.
- Top Cited Papers
- 20 August 2004
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 305 (5687) , 1157-1159
NOBOX Deficiency Disrupts Early Folliculogenesis and Oocyte-Specific Gene Expression
Primordial ovarian follicles in mice form when somatic cells surround individual oocytes. We show that lack of Nobox , an oocyte-specific homeobox gene, accelerates postnatal oocyte loss and abolishes the transition from primordial to growing follicles in mice. Follicles are replaced by fibrous tissue in female mice lacking Nobox in a manner similar to nonsyndromic ovarian failure in women. Genes preferentially expressed in oocytes, including Oct4 and Gdf9 , are down-regulated in Nobox –/– mice, whereas ubiquitous genes such as Bmp4, Kit , and Bax remain unaffected. Therefore, Nobox is critical for specifying an oocyte-restricted gene expression pattern essential for postnatal follicle development.
- 20 August 2004
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 305 (5687) , 1157-1159
Top Cited PapersNOBOX Deficiency Disrupts Early Folliculogenesis and Oocyte-Specific Gene Expression
Primordial ovarian follicles in mice form when somatic cells surround individual oocytes. We show that lack of Nobox , an oocyte-specific homeobox gene, accelerates postnatal oocyte loss and abolishes the transition from primordial to growing follicles in mice. Follicles are replaced by fibrous tissue in female mice lacking Nobox in a manner similar to nonsyndromic ovarian failure in women. Genes preferentially expressed in oocytes, including Oct4 and Gdf9 , are down-regulated in Nobox –/– mice, whereas ubiquitous genes such as Bmp4, Kit , and Bax remain unaffected. Therefore, Nobox is critical for specifying an oocyte-restricted gene expression pattern essential for postnatal follicle development.
- 24 April 2003
- Published by Wiley in Prenatal Diagnosis
- Vol. 23 (5) , 410-419
Identification of expressed sequence tags preferentially expressed in human placentas byin silico subtraction
- 24 April 2003
- Published by Wiley in Prenatal Diagnosis
- Vol. 23 (5) , 410-419
Identification of expressed sequence tags preferentially expressed in human placentas byin silico subtraction
- 1 September 1999
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 94 (3) , 355-360
Plasma homocyst(e)ine concentrations in eclamptic and preeclamptic african women postpartum
To examine the relationship between plasma homocyst(e)ine and risk of eclampsia and preeclampsia among sub-Saharan African women who delivered at Harare Maternity Hospital in Zimbabwe. We ran a hospital-based, case-control study at Harare Maternity Hospital, University of Zimbabwe, Harare, Zimbabwe comprising 33 pregnant women with eclampsia and 138 with preeclampsia. Controls were 185 normotensive pregnant women. Plasma was collected postpartum and homocyst(e)ine levels were measured by high-performance liquid chromatography and electrochemical detection. Women with eclampsia or preeclampsia had significantly higher mean homocyst(e)ine levels than normotensive controls (12.54 or 12.77 micromol/L versus 9.93 micromol/L, respectively, P<.001). The odds ratio (OR) for eclampsia was 6.03 among women in the highest quartile of the control homocyst(e)ine distribution (median 13.9 micromol/L) compared with women in the lowest quartile (median 6.2 micromol/L). The corresponding OR for preeclampsia was 4.57. Nulliparas with elevated homocyst(e)ine had a 12.90 times higher risk of preeclampsia compared with multiparas without elevated homocyst(e)ine. Postpartum plasma homocyst(e)ine concentrations are higher among Zimbabwean women with eclampsia and preeclampsia compared with normotensive women.
- 1 September 1999
- Published by Wolters Kluwer Health in Obstetrics & Gynecology
- Vol. 94 (3) , 355-360
Plasma homocyst(e)ine concentrations in eclamptic and preeclamptic african women postpartum
To examine the relationship between plasma homocyst(e)ine and risk of eclampsia and preeclampsia among sub-Saharan African women who delivered at Harare Maternity Hospital in Zimbabwe. We ran a hospital-based, case-control study at Harare Maternity Hospital, University of Zimbabwe, Harare, Zimbabwe comprising 33 pregnant women with eclampsia and 138 with preeclampsia. Controls were 185 normotensive pregnant women. Plasma was collected postpartum and homocyst(e)ine levels were measured by high-performance liquid chromatography and electrochemical detection. Women with eclampsia or preeclampsia had significantly higher mean homocyst(e)ine levels than normotensive controls (12.54 or 12.77 micromol/L versus 9.93 micromol/L, respectively, P<.001). The odds ratio (OR) for eclampsia was 6.03 among women in the highest quartile of the control homocyst(e)ine distribution (median 13.9 micromol/L) compared with women in the lowest quartile (median 6.2 micromol/L). The corresponding OR for preeclampsia was 4.57. Nulliparas with elevated homocyst(e)ine had a 12.90 times higher risk of preeclampsia compared with multiparas without elevated homocyst(e)ine. Postpartum plasma homocyst(e)ine concentrations are higher among Zimbabwean women with eclampsia and preeclampsia compared with normotensive women.